Business, Energy & Power, Lifestyle, Menus & Tastes, Science

Plopii launches nootropic nicotine-free focus, energy pouches powered by paraxanthine

Brooklyn biotech company debuts a line of nootropic focus and energy pouches powered by paraxanthine, caffeine’s primary active metabolite. The nicotine-free pouches arrive in five flavors as a cleaner alternative to caffeine.

BROOKLYN, N.Y. — PRNewswire — On June 29, Plopii announced the launch of its paraxanthine focus pouches, a nicotine-free nootropic energy pouch designed to deliver clean, sustained focus and jitter-free energy without the crash associated with traditional caffeine.

Each pouch is powered by 120mg of paraxanthine, the compound the body produces when it breaks down caffeine, and the molecule responsible for much of caffeine’s cognitive and energy benefits. By delivering paraxanthine directly, Plopii’s pouches are built to provide smoother energy and clearer focus with a gentler profile for sleep, anxiety, and tolerance.

The formula pairs paraxanthine with 60mg of Alpha-GPC, 60mg of Citicoline, & 60mg of L-theanine, a combination designed to support attention and calm, focused energy throughout the day.

“We built Plopii on a simple idea, that paraxanthine can do what caffeine does without what caffeine costs you,” said Michael Tolmach, Co-Founder and Chief Executive Officer of Plopii.

Plopii’s focus pouches come in five flavors: Cool Mint, Wintergreen, Tropical Mango, Blueberry, and Watermelon.

“We built these for the way people actually work, train, and create. A clean, repeatable lift you can reach for anytime, without rethinking your day,” said David Alexander, Co-Founder and Chief Operating Officer of Plopii.

Positioned as a nicotine-pouch alternative and an everyday caffeine alternative, the pouches are now available on Amazon, TikTok Shop, and at plopii.com.

About Plopii

Plopii is a Brooklyn-based wellness and biotechnology company focused on paraxanthine, caffeine’s primary active metabolite. The company develops consumer products and a pharmaceutical pipeline built around paraxanthine’s differentiated profile. Visit plopii.com.

CONTACT: info@plopii.com

SOURCE Plopii Inc.

Michelle Dryden (Author)

Michelle Dryden has come full-circle back to the exciting world of Journalism, news, and media. Dryden is an Independent Multimedia Journalist. She graduated with honors from Full Sail University. Dryden received the Advanced Achievement Award from Full Sail University's New Media Journalism Master's degree program, in June 2013. With journalism experiences in both digital and traditional journalism since 1996, she is a news veteran. The Media Pub News blog publishes core news and community features. What's your story? Email me at mdryden@themediapub.com. Cheers!!!

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.